indazoles has been researched along with Gliosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blute, T; Chen, CS; Ma, J; Waxman, DJ | 1 |
| Ben-Yoseph, O; Lyons, JC; Ross, BD; Song, CW | 1 |
2 other study(ies) available for indazoles and Gliosarcoma
| Article | Year |
|---|---|
Antiangiogenesis enhances intratumoral drug retention.
Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Cyclophosphamide; Drug Synergism; Gliosarcoma; Imidazoles; Indazoles; Male; Mice; Mice, Inbred ICR; Mice, SCID; Neovascularization, Pathologic; Random Allocation; Rats; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous | 2011 |
Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Gliosarcoma; Hydrogen-Ion Concentration; Indazoles; Injections, Subcutaneous; Intracellular Fluid; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Muscle Neoplasms; Neoplasm Transplantation; Phosphorus Radioisotopes; Rats; Rats, Inbred F344; Thigh | 1998 |